20 project partners from academia and industry have joined forces in the Bio2Brain network to investigate efficient administration routes of biopharmaceuticals for the treatment of disorders of the central nervous system (CNS). The challenge is an endogenous defence system that normally protects the CNS from unwanted substances. The downside, however, is that commercial or even potential drugs cannot readily cross this barrier.
In order to respond to this challenge, the Bio2Brain network will pursue more effective approaches and develop new paradigms for drug delivery technologies in the treatment of CNS diseases.
For more information: